Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

BackgroundCoronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice results...

Full description

Bibliographic Details
Main Authors: Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, Nan Sun, Ge Sun, Yuqiao Shen, Xiaolan Lin, Guiming Guo, Shengyan Xi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
Chinese Patent Medicines
pharmacological action
clinical application
Traditional Chinese Medicine
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01066/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.01066/full

Similar Items